Cristina Blanco-Andujar

Chief Technology Officer at MediSieve

Cristina Blanco-Andujar has held various positions throughout their career. Cristina started as a PhD student at University College London in 2009 and completed their studies in 2014. After that, they worked as a Research Associate at the Toyohashi University of Technology for a brief period in 2014.

In 2014, Blanco-Andujar joined CNRS as a Postdoctoral Researcher at the Institut de Physique et Chimie des Matériaux de Strasbourg (IPCMS). During their time there, they were involved in two projects in collaboration with clinical teams at hospitals in Strasbourg and Lyon. Their work included synthesis of magnetic materials, functionalization with RNA and complex sugars, experimental planning, and report writing. Cristina also trained PhD students on instrumentation use and project management and presented at international conferences. Blanco-Andujar remained at CNRS until October 2016.

Since 2016, Blanco-Andujar has been with MediSieve Limited. Cristina started as a University College London Research Associate in November 2016 and held this role until March 2017. From April 2017 to March 2018, they served as a Product Development Manager. From April 2018 to March 2019, they were the Head of Research and Development. Currently, they hold the position of Chief Technology Officer, starting in April 2019.

Overall, Cristina Blanco-Andujar's work experience includes roles in research, development, and leadership positions in the fields of material science, medical technology, and pharmaceuticals.

Cristina Blanco-Andujar completed an Executive Education Programme, Leading Teams for Emerging Leaders at the London Business School in 2019. Prior to this, they obtained their Doctor of Philosophy (PhD) in Nanomaterials for Biomedical applications from University College London, U. of London, between 2009 and 2014.

Before pursuing their PhD, Cristina Blanco-Andujar attended Nottingham Trent University, where they earned an MChem degree. Additionally, they obtained a Licentiate in Chemistry from Universitat Rovira i Virgili, although the start and end years for these degrees are not specified.

In terms of additional certifications, Cristina Blanco-Andujar obtained the CIEH Foundation Occupational Health and Safety certification from The Chartered Institute of Environmental Health in July 2019. Prior to that, in October 2018, they acquired the Biological Safety Specialist certification from NAMSA.

Links


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


MediSieve

1 followers

MediSieve is a multi-award-winning medical device company developing Magnetic Blood Filtration (MBF), a platform technology for the treatment of blood-borne diseases by physically removing disease relevant targets directly from a patient’s bloodstream. MBF is an extracorporeal technology, similar to dialysis. A patient's blood is continuouslycirculated through an external blood loop containing the MediSieve system. Targeted magnetic particles (TB-MPs) are infused into the loop, binding specifically to disease-relevant targets in the patient's blood. The blood then flows through a magnetic filter which captures the particles and bound targets and the remainder of the blood returns to the patient unaffected; the TB-MPs never enter the patient’s body.MediSieve is based at the Imperial Incubator in White City, London. It has dedicated workshop and laboratory facilities (including capacity for ELISAs, Flow Cytometry and human blood testing) in which products are developed and validated.


Employees

11-50

Links